Table 2.
ASCVD Risk Factors in Study Population (ADA Guidelines)
| Risk Factors | Number (%) |
|---|---|
| Overweight or obese (BMI ≥23 kg/m2 in Asian Americans) (N=2808) | 2338 (83.3%) |
| Family history of diabetes (N=2201) | 1104 (50.2%) |
| HTN:≥140/90 mmHg (N=3603) * | 926 (25.7%) |
| History of CVD**(N=2201) | IHD/CAD: 83 (3.8%) |
| CHD: 80 (3.6%) | |
| HDL cholesterol level <35 mg/dL (0.90 mmol/L) and/or a triglyceride level >250 mg/dL (2.82 mmol/L)** | |
| HDL <40 mg/dL (N=2497) | 599 (24%) |
| TG >250 mg/dL (N=2564) | 419 (16.3%) |
| Additional ASCVD risk factors | |
| LDL cholesterol ≥100 mg/dL (2.6 mmol/L)(N=2545) | 1766 (69.4%) |
| Chronic kidney disease (patients with Stage 3–5 based on CKD-EPI)(N=1800) | 491 (27.3%) |
Notes: *135 patients overlapping; **9 patients overlapping.
Abbreviations: ASCVD, arteriosclerotic cardiovascular disease; BMI, body mass index; CHD, coronary heart disease; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; CVD, cardiovascular disease; HDL-C, high-density lipoproteins cholesterol; IHD, ischemic heart disease; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; CAD, coronary artery disease.